MedCity News | How the IRA Has Created a New Environment for Biosimilars

By Maximillian Vargas and Caitlin Verrilli

As IRA provisions are activated, the law’s impact on biologics and biosimilars will become more apparent. By using both the carrot and the stick, the IRA may finally…